Wells Fargo Downgrades Vitae Pharmaceuticals (VTAE) to Market Perform

September 15, 2016 7:11 AM EDT
Get Alerts VTAE Hot Sheet
Price: $21.00 +0.05%

Rating Summary:
    1 Buy, 5 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 26 | Down: 29 | New: 38
Trade VTAE Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Wells Fargo downgraded Vitae Pharmaceuticals (NASDAQ: VTAE) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Vitae Pharmaceuticals click here. For more ratings news on Vitae Pharmaceuticals click here.

Shares of Vitae Pharmaceuticals closed at $20.85 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Wells Fargo

Add Your Comment